GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher

Shares of GlucoTrack, Inc. (NASDAQ:GCTK) traded up 2.9% during mid-day trading on Wednesday . The company traded as high as $1.73 and last traded at $1.73. 2,524 shares were traded during trading, a decline of 92% from the average session volume of 31,967 shares. The stock had previously closed at $1.68.

GlucoTrack Stock Performance

The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.31 and a current ratio of 1.31. The stock has a market cap of $9.48 million, a P/E ratio of -0.84 and a beta of 0.06. The business’s 50-day moving average price is $2.40 and its 200-day moving average price is $1.86.

GlucoTrack (NASDAQ:GCTK) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.60) earnings per share (EPS) for the quarter.

Insider Activity at GlucoTrack

In other news, Director Drew Sycoff purchased 36,508 shares of the stock in a transaction on Monday, April 22nd. The shares were acquired at an average price of $6.30 per share, with a total value of $230,000.40. Following the completion of the acquisition, the director now directly owns 590,251 shares of the company’s stock, valued at $3,718,581.30. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 17.70% of the stock is currently owned by corporate insiders.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.